Referencias correspondientes a la pieza LKC 008

1- Licari , et al. Emerging drugs for the treatment of perennial allergic rhinitis. Expert Opin Emerg Drugs. 2016;21(1):57-67.

2- Baena, et al. Actualización de rinitis alérgica y su impacto en el asma (ARIA 2008). La perspectiva latinoamericana. Revista Alergia Mexico. 56. 56-63.

3- Vázquez, Medina, Gattolín, Parisi,Logusso,Arias.  Estudio Nacional de Prevalencia de Rinitis Alérgica en Argentina(PARA 2017).

4- Wheatley, et al. Rinitis alérgica Descripción, revisión de guías basadas en evidencias y recomendaciones clínicas de la rinitis alérgica. N Engl J Med 2015; 372: 456-63.

5- Uptodate: patogénesis of allergic rhinitis rhinosinusitis  [Internet] [Consultado el 20 enero 2018]  Disponible en: www.uptodate.com/

6- Sole, et al. Impacto sobre la calidad de vida y el desempeño en adultos y niños con rinitis alérgica en Latinoamérica.

7- Bousquet J, et al. The Workshop Expert Panel. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 86S:1–160, 2008.

8- Thomson L, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 32:1187–1192, 2002.

9- Jerazawi E. Effect of levocetirizine on eotaxin induced eosinophil chemotaxis with and without interleukin 5 proming in vitro. Allergy 56(suppl 68):138, 2001

10- Ciebiada M, et al. Montelukast with desloratadine or levocetirizine for he treatment of persistent allergic rhinitis. Ann Allergy Asthma Immunol 97:664–671,
2006.

11-  Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitised to house dust mites. Allergy 58:893–899, 2003

12- Nayak AS, et al. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 56:1077–1080,2001.

13- Meltzer EO, et al. Desloratadine Study Group. Efficacy and tolerability of once daily 5 mg desloratadine an H1 receptor antagonist in patients with seasonal allergic rhinitis. Clin Drug Invest 21:25–32, 2001.

14- de Blic J, et al. Levocetirizine in children: Evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol 16:267–275, 2005.

15- Henz BM. The pharmacologic profile of desloratadine: A review. Allergy 56(suppl 65):7–13, 2001.

16- van Adelsberg J, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4 week treatment period. Allergy 58:1268–1276, 2003.

17- Meltzer EO, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo controlled clinical trial. J Allergy Clin Immunol 105:917–922, 2000

18- Patel P, et al. Randomized, double-blind, placebocontrolled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 95:551–557, 2005.

19- Lagos JA, Marshall GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag. 2007;3:327–32.

20- McLeod RL et al. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion. Am J Rhinol Allergy 23:e17–e22, 2009.

21- Adsule , et al. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence. Indian Med Assoc. 2010 Jun;108(6):381-2.

22- Ciebiada , etl al. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy. 2011 Jan-Feb;25(1):e1-6.

23- Mullol J, et al. Management of persistent allergic rhinitis: Evidence-based treatment with levocetirizine. Ther Clin Risk Manag. 2005;1:265–71.

24- Gupta V, Matreja PS. Efficacy of montelukast and levocetirizine as treatment for allergic rhinitis. J Allergy Ther. 2010;1:103.

25- Ciebiada M. et al. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or  desloratadine. J Investig Allergol Clin Immunol. 2008;18:343–

26- Mohini Sachin Mahatme , et al. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial